Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2269-2278

  Pérot, Gaëlle ^a,b   Derré, Josette ^a,b   Coindre, Jean Michel ^c   Tirode, Franck ^a,b   Lucchesi, Carlo ^a,b   Mariani, Odette ^a,b   Gibault, Laure ^a,b   Guillou, Louis ^d   Terrier, Philippe ^e   Aurias, Alain ^a,b,f  

^a INSTITUT CURIE   (France)

^b INSERM   (France)

^c INSTITUT BERGONIÉ   (France)

^d UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MYOCARDIN; SHORT HAIRPIN RNA; NUCLEAR PROTEIN; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL MIGRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENE LOCUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEIOMYOSARCOMA; LIPOSARCOMA; MESENCHYMOMA; PHENOTYPE; PRIORITY JOURNAL; RETROPERITONEAL SARCOMA; SARCOMA CELL; SMOOTH MUSCLE; TISSUE DIFFERENTIATION; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL MOTION; CHROMOSOME 17; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETROPERITONEAL TUMOR; TUMOR CELL LINE; UPREGULATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CHROMOSOMES, HUMAN, PAIR 17; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LEIOMYOSARCOMA; MUSCLE, SMOOTH; NUCLEAR PROTEINS; RETROPERITONEAL NEOPLASMS; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; UP-REGULATION;

EID: 65549111844     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1443     Document Type: Article

References (45)

1. Fletcher CDM, Unni KK, Mertens V, editors. World Health Organisation classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002.
2. Derré J, Lagacé R, Nicolas A, et al. Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab Invest 2001;81:211-5.
3. Fletcher CD. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 2006;48:3-12.
4. Chibon F, Mairal A, Fréneaux P, et al. The RBI gene is the target of chromosome 13 deletions in malignant fibrous histiocytoma Cancer Res 2000;60: 6339-45.
5. Otaño-joos M, Mechtersheimer G, Ohl S, et al. Detection of chromosomal imbalances in leiomyosarcoma by comparative genomic hybridization and interphase cytogenetics. Cytogenet Cell Genet 2000;90: 86-92.
6. Hu J, Rao UN, jasani S, Khanna V, Yaw K, Surti U. Loss of DKA copy number of lOq is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study. Cancer Genet Cytogenet 2005;161:20-7.
7. Du KL, Ip HS, Li J, et al. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol 2003;23:2425-37.
8. Wang Z, Wang DZ, Pipes GC, Olson EN. Myocardin is a master regulator of smooth muscle gene expression, Proc Natl Acad Sci U S A2003;100:7129-34.
9. Pipes GC, Creemers EE, Olson EN. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev 2006;20:1545-56.
10. Vincent-Salomon A, Gruel N, Lucchesi C, et al. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res 2007;9:R24.
11. Wu Z, Irizarry RA, Gentleman R, Murillo I'M, Spencer F. A model based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 2004;99:909-17.
12. Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, Delattre O. Mesenchymal stem cell features of Ewing tumors. Cancer Cell 2007;11:421-9.
13. De Preter K, Speleman F, Combaret V, et al. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod Pathol 2002;15:159-66.
14. Wang Z, Wang DZ, Hockemeyer D, McAnally j, Nordheim A, Olson EN. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004;428:185-9.
15. Culhane AC, Perrière G, Considine EC, Cotter TG, Higgins DG. Between-group analysis of microarray data. Bioinformatics 2002;18:1600-8.
16. Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH, Owens GK. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression, J Biol Chem 2005;280:9719-27.
17. Holycross BJ, Blank RS, Thompson MM, Peach MJ, Owens GK. Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res 1992;71:1525-32.
18. Chen J, Kitchen CM, Streb JW, Miano JM. Myocardin: a component of a molecular switch for smooth muscle differentiation, J Mol Cell Cardiol 2002;34:1345-56.
19. Wang DZ, Olson EN. Control of smooth muscle development by the myocardin family of transcriptional coactivators, Curr Opin Genet Dev 2004;14:558-66.
20. Yoshida T, Sinha S, Dandré F, et al. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 2003; 92:856-64.
21. van Tuyn J, Knaǎn-Shanzer S, van de Watering MJ, et al. Activation of cardiac and smooth muscle-specific genes in primary' human cells after forced expression of human myocardin. Cardiovasc Res 2005;67:245-55.
22. Gorenne I, jin L, Yoshida T, et al. LPP expression during in vitro smooth muscle differentiation and stent- induced vascular injury. Circ Res 2006;98:378-85.
23. Majesky MW. Organizing motility: LIM domains, LPP, and smooth muscle migration. Circ Res 2006;98:306-8.
24. Petit. MM, Lindskog H, Larsson E, et al. Smooth muscle expression of lipoma preferred partner is mediated by an alternative intronic promoter that is regulated by serum response factor/myocardin. Circ Res 2008;103:61-9.
25. Ghafar MA, Anastasiadis AG, Chen MW, et al. Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells. Prostate 2003;54:58-67.
26. Helczynska K, Kronblad A, jǒgi A, et al. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 2003;63:1441-4.
27. Abelev GI, Lazarevich NL. Control of differentiation in progression of epithelial tumors. Adv Cancer Res 2006;95:61-113.
28. Cheuk W, Chan JK. Advances in salivary gland pathology. Histopathology 2007;51:1-20.
29. van Staveren WC, Soli'́s DW, Delys L, et al. Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype. Cancer Res 2007;67:8113-20.
30. Edsjö A, Holmquist L, Påhlman S. Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation. Semin Cancer Biol 2007;17:248-56.
31. Mariani O, Brennetot C, Coindre JM, et al. JUN oncogene amplification and overexpression block adipocyte differentiation In highly aggressive sarcomas. Cancer Cell 2007;11:361-74.
32. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995;75:487-517.
33. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801.
34. Hellstrand P, Albinsson S. Stretch-dependent growth and differentiation in vascular smooth muscle: role of the actin cytoskeleton. Can J Physiol Pharmacol 2005:83: 869-75.
35. Inoue K, Dewar K, Katsanis N, et al. The 1,4-Mb CMT1A duplieation/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes. Genome Res 2001;11:1018-33.
36. Park SS, Stankiewiez P, Bi W, et al. Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs. Genome Res 2002;12:729-38.
37. Forus A, Weghuis DO, Smeete D, Fodstad O, Myklebost O, Geurts van Kessel A. Comparative genomic hybridization analysis of human sarcomas, II. Identification of novel amplicons at 6p and 17p In osteosarcomas. Genes Chromosomes Cancer 1995;14:15-21.
38. Frǔhwald MC, O'Dorisio MS, Dai Z, et al. Aberrant hypermethylation of the major breakpoint cluster region in 17pll,2 in medulloblastomas but not supratentorial PNETs. Genes Chromosomes Cancer 2001;30:38-47.
39. van Dartel M, Cornelissen PW, Redeker S, et al. Amplification of 17p11.2 approximately pl2, Including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma. Cancer Genet Cytogenet 2002;139:91-6.
40. El-Rifai W, Sarlomo-Rikala M, Knuutila S, Miettinen M. DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am J Pathol 1998;153:985-90.
41. Wolf M, Tarkkanen M, Hulsebos T, et al. Characterization of the 17p amplicon in human sarcomas: microsatellite marker analysis, Int J Cancer 1999;82: 329-33.
42. Wang DZ, Li S, Hockemeyer D, et al. Potentiation of serum response factor activity by a family of myocardin- related transcription factors. Proc Natl Acad Sci U S A 2002;99:14855-60.
43. Du KL, Chen M, Li J, Lepore jj, Mericko P, Parmacek MS. Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells.) Biol Chem 2004;279:17578-86.
44. Selvaraj A, Prywes R. Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent BMC Mol Biol 2004;5:13.
45. Farshid G, Pradhan M, Goldblum j, Weiss SW. Leiomyosarcoma of somatic soft tissues: a tumor of vascular origin with multivariate analysis of outcome in 42 cases. Am J Surg Pathol 2002;26:14-24.